CD19 and B-cell chronic lymphocytic leukemia: CD19 is broadly and homogeneously expressed across B-cell malignancies, including diffuse large B-cell lymphoma (DLBCL), chronic lymphocytic leukemia (CLL), Burkitt’s lymphoma (BL), and mantle cell lymphoma (MCL) [3].